Differences in height explain gender differences in the response to the oral glucose tolerance test- the AusDiab study
Aim To determine the extent of gender‐related differences in the prevalence of glucose intolerance for the Australian population and whether body size may explain such differences. Methods Cross‐sectional data were collected from a national cohort of 11 247 Australians aged ≥ 25 years. Glucose tol...
Gespeichert in:
| Veröffentlicht in: | Diabetic medicine 2008-03, Vol.25 (3), p.296-302 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 302 |
|---|---|
| container_issue | 3 |
| container_start_page | 296 |
| container_title | Diabetic medicine |
| container_volume | 25 |
| creator | Sicree, R. A. Zimmet, P. Z. Dunstan, D. W. Cameron, A. J. Welborn, T. A. Shaw, J. E. |
| description | Aim To determine the extent of gender‐related differences in the prevalence of glucose intolerance for the Australian population and whether body size may explain such differences.
Methods Cross‐sectional data were collected from a national cohort of 11 247 Australians aged ≥ 25 years. Glucose tolerance status was assessed according to both fasting plasma glucose (FPG) and 2‐h plasma glucose (2hPG) levels following a 75‐g oral glucose tolerance test (OGTT). Anthropometric and glycated haemoglobin measurements were also made.
Results Undiagnosed diabetes and non‐diabetic glucose abnormalities were more prevalent among men than women when based only on the FPG results (diabetes: men 2.2%, women 1.6%, P = 0.02; impaired fasting glycaemia: men 12.3%, women 6.6%, P |
| doi_str_mv | 10.1111/j.1464-5491.2007.02362.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70352951</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70352951</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5012-594aab60ebe2ebdcea879b8e1e6baa96cdec4d72c94b8cee6bbec0b36feebf223</originalsourceid><addsrcrecordid>eNqNkEFv0zAUxy0EYt3gKyBf4JZgO46dHDhM69iQVpgEiKNlOy-ti5sUO4H2289pqyJu-GK_59_ffvohhCnJaVrv1znlgmclr2nOCJE5YYVg-e4Zmp0vnqMZkZxlBZH0Al3GuCaEsrqoX6ILWqUuL-UM_Z67toUAnYWIXYdX4JarAcNu63Uql9A1EHDzLzSsAAeI276LgIf-UPdBe7z0o-0PPQ9BJxwPEIfsAFyPce60wXEYm_0r9KLVPsLr036Fvn-8_XZznz18uft0c_2Q2TINm5U119oIAgYYmMaCrmRtKqAgjNa1sA1Y3khma24qC6lrwBJTiBbAtIwVV-jd8d1t6H-NaRa1cdGC97qDfoxKkqJkdUkTWB1BG_oYA7RqG9xGh72iRE3O1VpNatWkVk3O1cG52qXom9Mfo9lA8zd4kpyAtydAR6t9O5lx8cwxQoWoqjJxH47cH-dh_98DqPnidjqlfHbMuzjA7pzX4acSspCl-vH5Tt0vvi7442OlWPEE1V2vdQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70352951</pqid></control><display><type>article</type><title>Differences in height explain gender differences in the response to the oral glucose tolerance test- the AusDiab study</title><source>Wiley Online Library - AutoHoldings Journals</source><source>MEDLINE</source><creator>Sicree, R. A. ; Zimmet, P. Z. ; Dunstan, D. W. ; Cameron, A. J. ; Welborn, T. A. ; Shaw, J. E.</creator><creatorcontrib>Sicree, R. A. ; Zimmet, P. Z. ; Dunstan, D. W. ; Cameron, A. J. ; Welborn, T. A. ; Shaw, J. E.</creatorcontrib><description>Aim To determine the extent of gender‐related differences in the prevalence of glucose intolerance for the Australian population and whether body size may explain such differences.
Methods Cross‐sectional data were collected from a national cohort of 11 247 Australians aged ≥ 25 years. Glucose tolerance status was assessed according to both fasting plasma glucose (FPG) and 2‐h plasma glucose (2hPG) levels following a 75‐g oral glucose tolerance test (OGTT). Anthropometric and glycated haemoglobin measurements were also made.
Results Undiagnosed diabetes and non‐diabetic glucose abnormalities were more prevalent among men than women when based only on the FPG results (diabetes: men 2.2%, women 1.6%, P = 0.02; impaired fasting glycaemia: men 12.3%, women 6.6%, P < 0.001). In contrast 16.0% of women and 13.0% of men had a 2hPG abnormality (either diabetes or impaired glucose tolerance, P = 0.14). Women had a mean FPG 0.3 mmol/l lower than men (P < 0.001), but 2hPG 0.3 mmol/l higher (P = 0.002) and FPG‐2hPG increment 0.5 mmol/l greater (P < 0.001). The gender difference in mean 2hPG and FPG‐2hPG increment disappeared following adjustment for height. For both genders, those in the shortest height quartile had 2hPG levels 0.5 mmol/l higher than the tallest quartile, but height showed almost no relationship with the FPG.
Conclusions Men and women had different glycaemic profiles; women had higher mean 2hPG levels, despite lower fasting levels. It appeared that the higher 2hPG levels for women related to lesser height and may be a consequence of using a fixed glucose load in the OGTT, irrespective of body size.</description><identifier>ISSN: 0742-3071</identifier><identifier>EISSN: 1464-5491</identifier><identifier>DOI: 10.1111/j.1464-5491.2007.02362.x</identifier><identifier>PMID: 18307457</identifier><identifier>CODEN: DIMEEV</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adult ; Australia - epidemiology ; Biological and medical sciences ; Blood Glucose - metabolism ; Body Height ; Diabetes Mellitus, Type 2 - epidemiology ; Diabetes Mellitus, Type 2 - metabolism ; Diabetes. Impaired glucose tolerance ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Epidemiologic Methods ; epidemiology ; Etiopathogenesis. Screening. Investigations. Target tissue resistance ; Feeding. Feeding behavior ; Female ; Fundamental and applied biological sciences. Psychology ; Glucose Tolerance Test ; Humans ; Male ; Medical sciences ; Middle Aged ; oral glucose tolerance test ; physiology ; Sex Characteristics ; Type 2 diabetes mellitus ; Vertebrates: anatomy and physiology, studies on body, several organs or systems ; Vertebrates: endocrinology</subject><ispartof>Diabetic medicine, 2008-03, Vol.25 (3), p.296-302</ispartof><rights>2008 The Authors.</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5012-594aab60ebe2ebdcea879b8e1e6baa96cdec4d72c94b8cee6bbec0b36feebf223</citedby><cites>FETCH-LOGICAL-c5012-594aab60ebe2ebdcea879b8e1e6baa96cdec4d72c94b8cee6bbec0b36feebf223</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1464-5491.2007.02362.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1464-5491.2007.02362.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,782,786,1419,27931,27932,45581,45582</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20166885$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18307457$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sicree, R. A.</creatorcontrib><creatorcontrib>Zimmet, P. Z.</creatorcontrib><creatorcontrib>Dunstan, D. W.</creatorcontrib><creatorcontrib>Cameron, A. J.</creatorcontrib><creatorcontrib>Welborn, T. A.</creatorcontrib><creatorcontrib>Shaw, J. E.</creatorcontrib><title>Differences in height explain gender differences in the response to the oral glucose tolerance test- the AusDiab study</title><title>Diabetic medicine</title><addtitle>Diabet Med</addtitle><description>Aim To determine the extent of gender‐related differences in the prevalence of glucose intolerance for the Australian population and whether body size may explain such differences.
Methods Cross‐sectional data were collected from a national cohort of 11 247 Australians aged ≥ 25 years. Glucose tolerance status was assessed according to both fasting plasma glucose (FPG) and 2‐h plasma glucose (2hPG) levels following a 75‐g oral glucose tolerance test (OGTT). Anthropometric and glycated haemoglobin measurements were also made.
Results Undiagnosed diabetes and non‐diabetic glucose abnormalities were more prevalent among men than women when based only on the FPG results (diabetes: men 2.2%, women 1.6%, P = 0.02; impaired fasting glycaemia: men 12.3%, women 6.6%, P < 0.001). In contrast 16.0% of women and 13.0% of men had a 2hPG abnormality (either diabetes or impaired glucose tolerance, P = 0.14). Women had a mean FPG 0.3 mmol/l lower than men (P < 0.001), but 2hPG 0.3 mmol/l higher (P = 0.002) and FPG‐2hPG increment 0.5 mmol/l greater (P < 0.001). The gender difference in mean 2hPG and FPG‐2hPG increment disappeared following adjustment for height. For both genders, those in the shortest height quartile had 2hPG levels 0.5 mmol/l higher than the tallest quartile, but height showed almost no relationship with the FPG.
Conclusions Men and women had different glycaemic profiles; women had higher mean 2hPG levels, despite lower fasting levels. It appeared that the higher 2hPG levels for women related to lesser height and may be a consequence of using a fixed glucose load in the OGTT, irrespective of body size.</description><subject>Adult</subject><subject>Australia - epidemiology</subject><subject>Biological and medical sciences</subject><subject>Blood Glucose - metabolism</subject><subject>Body Height</subject><subject>Diabetes Mellitus, Type 2 - epidemiology</subject><subject>Diabetes Mellitus, Type 2 - metabolism</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Epidemiologic Methods</subject><subject>epidemiology</subject><subject>Etiopathogenesis. Screening. Investigations. Target tissue resistance</subject><subject>Feeding. Feeding behavior</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Glucose Tolerance Test</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>oral glucose tolerance test</subject><subject>physiology</subject><subject>Sex Characteristics</subject><subject>Type 2 diabetes mellitus</subject><subject>Vertebrates: anatomy and physiology, studies on body, several organs or systems</subject><subject>Vertebrates: endocrinology</subject><issn>0742-3071</issn><issn>1464-5491</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkEFv0zAUxy0EYt3gKyBf4JZgO46dHDhM69iQVpgEiKNlOy-ti5sUO4H2289pqyJu-GK_59_ffvohhCnJaVrv1znlgmclr2nOCJE5YYVg-e4Zmp0vnqMZkZxlBZH0Al3GuCaEsrqoX6ILWqUuL-UM_Z67toUAnYWIXYdX4JarAcNu63Uql9A1EHDzLzSsAAeI276LgIf-UPdBe7z0o-0PPQ9BJxwPEIfsAFyPce60wXEYm_0r9KLVPsLr036Fvn-8_XZznz18uft0c_2Q2TINm5U119oIAgYYmMaCrmRtKqAgjNa1sA1Y3khma24qC6lrwBJTiBbAtIwVV-jd8d1t6H-NaRa1cdGC97qDfoxKkqJkdUkTWB1BG_oYA7RqG9xGh72iRE3O1VpNatWkVk3O1cG52qXom9Mfo9lA8zd4kpyAtydAR6t9O5lx8cwxQoWoqjJxH47cH-dh_98DqPnidjqlfHbMuzjA7pzX4acSspCl-vH5Tt0vvi7442OlWPEE1V2vdQ</recordid><startdate>200803</startdate><enddate>200803</enddate><creator>Sicree, R. A.</creator><creator>Zimmet, P. Z.</creator><creator>Dunstan, D. W.</creator><creator>Cameron, A. J.</creator><creator>Welborn, T. A.</creator><creator>Shaw, J. E.</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200803</creationdate><title>Differences in height explain gender differences in the response to the oral glucose tolerance test- the AusDiab study</title><author>Sicree, R. A. ; Zimmet, P. Z. ; Dunstan, D. W. ; Cameron, A. J. ; Welborn, T. A. ; Shaw, J. E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5012-594aab60ebe2ebdcea879b8e1e6baa96cdec4d72c94b8cee6bbec0b36feebf223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adult</topic><topic>Australia - epidemiology</topic><topic>Biological and medical sciences</topic><topic>Blood Glucose - metabolism</topic><topic>Body Height</topic><topic>Diabetes Mellitus, Type 2 - epidemiology</topic><topic>Diabetes Mellitus, Type 2 - metabolism</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Epidemiologic Methods</topic><topic>epidemiology</topic><topic>Etiopathogenesis. Screening. Investigations. Target tissue resistance</topic><topic>Feeding. Feeding behavior</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Glucose Tolerance Test</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>oral glucose tolerance test</topic><topic>physiology</topic><topic>Sex Characteristics</topic><topic>Type 2 diabetes mellitus</topic><topic>Vertebrates: anatomy and physiology, studies on body, several organs or systems</topic><topic>Vertebrates: endocrinology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sicree, R. A.</creatorcontrib><creatorcontrib>Zimmet, P. Z.</creatorcontrib><creatorcontrib>Dunstan, D. W.</creatorcontrib><creatorcontrib>Cameron, A. J.</creatorcontrib><creatorcontrib>Welborn, T. A.</creatorcontrib><creatorcontrib>Shaw, J. E.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetic medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sicree, R. A.</au><au>Zimmet, P. Z.</au><au>Dunstan, D. W.</au><au>Cameron, A. J.</au><au>Welborn, T. A.</au><au>Shaw, J. E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differences in height explain gender differences in the response to the oral glucose tolerance test- the AusDiab study</atitle><jtitle>Diabetic medicine</jtitle><addtitle>Diabet Med</addtitle><date>2008-03</date><risdate>2008</risdate><volume>25</volume><issue>3</issue><spage>296</spage><epage>302</epage><pages>296-302</pages><issn>0742-3071</issn><eissn>1464-5491</eissn><coden>DIMEEV</coden><abstract>Aim To determine the extent of gender‐related differences in the prevalence of glucose intolerance for the Australian population and whether body size may explain such differences.
Methods Cross‐sectional data were collected from a national cohort of 11 247 Australians aged ≥ 25 years. Glucose tolerance status was assessed according to both fasting plasma glucose (FPG) and 2‐h plasma glucose (2hPG) levels following a 75‐g oral glucose tolerance test (OGTT). Anthropometric and glycated haemoglobin measurements were also made.
Results Undiagnosed diabetes and non‐diabetic glucose abnormalities were more prevalent among men than women when based only on the FPG results (diabetes: men 2.2%, women 1.6%, P = 0.02; impaired fasting glycaemia: men 12.3%, women 6.6%, P < 0.001). In contrast 16.0% of women and 13.0% of men had a 2hPG abnormality (either diabetes or impaired glucose tolerance, P = 0.14). Women had a mean FPG 0.3 mmol/l lower than men (P < 0.001), but 2hPG 0.3 mmol/l higher (P = 0.002) and FPG‐2hPG increment 0.5 mmol/l greater (P < 0.001). The gender difference in mean 2hPG and FPG‐2hPG increment disappeared following adjustment for height. For both genders, those in the shortest height quartile had 2hPG levels 0.5 mmol/l higher than the tallest quartile, but height showed almost no relationship with the FPG.
Conclusions Men and women had different glycaemic profiles; women had higher mean 2hPG levels, despite lower fasting levels. It appeared that the higher 2hPG levels for women related to lesser height and may be a consequence of using a fixed glucose load in the OGTT, irrespective of body size.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>18307457</pmid><doi>10.1111/j.1464-5491.2007.02362.x</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0742-3071 |
| ispartof | Diabetic medicine, 2008-03, Vol.25 (3), p.296-302 |
| issn | 0742-3071 1464-5491 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_70352951 |
| source | Wiley Online Library - AutoHoldings Journals; MEDLINE |
| subjects | Adult Australia - epidemiology Biological and medical sciences Blood Glucose - metabolism Body Height Diabetes Mellitus, Type 2 - epidemiology Diabetes Mellitus, Type 2 - metabolism Diabetes. Impaired glucose tolerance Endocrine pancreas. Apud cells (diseases) Endocrinopathies Epidemiologic Methods epidemiology Etiopathogenesis. Screening. Investigations. Target tissue resistance Feeding. Feeding behavior Female Fundamental and applied biological sciences. Psychology Glucose Tolerance Test Humans Male Medical sciences Middle Aged oral glucose tolerance test physiology Sex Characteristics Type 2 diabetes mellitus Vertebrates: anatomy and physiology, studies on body, several organs or systems Vertebrates: endocrinology |
| title | Differences in height explain gender differences in the response to the oral glucose tolerance test- the AusDiab study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T04%3A15%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differences%20in%20height%20explain%20gender%20differences%20in%20the%20response%20to%20the%20oral%20glucose%20tolerance%20test-%20the%20AusDiab%20study&rft.jtitle=Diabetic%20medicine&rft.au=Sicree,%20R.%20A.&rft.date=2008-03&rft.volume=25&rft.issue=3&rft.spage=296&rft.epage=302&rft.pages=296-302&rft.issn=0742-3071&rft.eissn=1464-5491&rft.coden=DIMEEV&rft_id=info:doi/10.1111/j.1464-5491.2007.02362.x&rft_dat=%3Cproquest_cross%3E70352951%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70352951&rft_id=info:pmid/18307457&rfr_iscdi=true |